Literature DB >> 18816261

Management [corrected] of conversions to cardiopulmonary bypass in beating heart coronary surgery.

Emir Mujanović1, Jacob Bergsland, Sanja Stanimirović-Mujanović, Emir Kabil.   

Abstract

This study investigated outcomes in patients undergoing coronary artery bypass grafting (CABG) without cardiopulmonary bypass (CPB), who needed conversion to CPB. Between September, 1998 and September, 2003, 1000 CABG procedures were performed in a Cardiovascular Clinic, University Clinical Centre Tuzla. Multivessel CABG were selected arbitrarily for CABG without CPB (OPCAB) or CABG with CPB (ONCAB). Patients who required conversion due to technical difficulty with grafting were performed with ONCAB including cardioplegic arrest. Patients with severe hemodynamic instability and cardiac arrest were performed as ONCAB without crossclamping, while patients converted for mild to moderate hemodynamic instability were given cardioplegic arrest or not, depending on surgeon preference. 493 operations were scheduled and performed as ONCAB (49.3%), 468 as OPCAB (46.8%) and 39 originally scheduled OPCAB operations were converted to ONCAB (7.7% of originally scheduled OPCAB patients or 3.9% of total number of CABG). Reasons for conversions were: mild to severe hemodynamic instability--28 (71.8%); poor vessels or difficult graft revision--11 (28.2%). Patients converted because of technical difficulty or mild hemodynamic instability behaved as regular ONCAB patients. In the 9 patients who were emergently converted due to cardiac arrest or ventricular fibrillation, 3 patients had stroke and 3 severe myocardial ischemia requiring intraaortic balloon pump. It is of great importance to keep conversions to CPB due to cardiac arrest at a low level. The serious complications seen in such patients can significantly impede the overall benefits of a successful OPCAB program.

Entities:  

Mesh:

Year:  2008        PMID: 18816261      PMCID: PMC5694680          DOI: 10.17305/bjbms.2008.2931

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  8 in total

1.  Conversion to cardiopulmonary bypass in off-pump coronary artery bypass grafting: its effect on outcome.

Authors:  P Soltoski; T Salerno; L Levinsky; S Schmid; S Hasnain; T Diesfeld; C Huang; M Akhter; O Alnoweiser; J Bergsland
Journal:  J Card Surg       Date:  1998 Sep-Oct       Impact factor: 1.620

2.  Coronary artery bypass grafting (CABG) without cardiopulmonary bypass (CPB): a strategy for improving results in surgical revascularization.

Authors:  J Bergsland; S Schmid; J Yanulevich; S Hasnain; T Z Lajos; T A Salerno
Journal:  Heart Surg Forum       Date:  1998       Impact factor: 0.676

3.  A review of transit-time flow measurement for assessing graft patency.

Authors:  D J VanHimbergen; S C Koenig; S F Jaber; P B Cerrito; P A Spence
Journal:  Heart Surg Forum       Date:  1999       Impact factor: 0.676

4.  "Single suture" for circumflex exposure in off-pump coronary artery bypass grafting.

Authors:  J Bergsland; H L Karamanoukian; P R Soltoski; T A Salerno
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

5.  Flow measurement in coronary surgery.

Authors:  G D'Ancona; H L Karamanoukian; T A Salerno; S Schmid; J Bergsland
Journal:  Heart Surg Forum       Date:  1999       Impact factor: 0.676

6.  Transit time flow measurements in coronary surgery: the experience from a new center in Bosnia.

Authors:  Emir Mujanovic; Emir Kabil; Mehdin Hadziselimovic; Muniba Softic; Azur Azabagic; Jacob Bersland
Journal:  Heart Surg Forum       Date:  2002       Impact factor: 0.676

7.  Initial experience using an intraluminal shunt during revascularization of the beating heart.

Authors:  L A Rivetti; S M Gandra
Journal:  Ann Thorac Surg       Date:  1997-06       Impact factor: 4.330

8.  Graft revision after transit time flow measurement in off-pump coronary artery bypass grafting.

Authors:  G D'Ancona; H L Karamanoukian; M Ricci; S Schmid; J Bergsland; T A Salerno
Journal:  Eur J Cardiothorac Surg       Date:  2000-03       Impact factor: 4.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.